Anti-ZDHHC16 monoclonal antibody

Pre-made anti-ZDHHC16 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to ZDHHC16/ZDHHC16 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2303-Ab-1/ GM-Tg-hg-IP2303-Ab-2Anti-Human ZDHHC16 monoclonal antibodyHuman
GM-Tg-rg-IP2303-Ab-1/ GM-Tg-rg-IP2303-Ab-2Anti-Rat ZDHHC16 monoclonal antibodyRat
GM-Tg-mg-IP2303-Ab-1/ GM-Tg-mg-IP2303-Ab-2Anti-Mouse ZDHHC16 monoclonal antibodyMouse
GM-Tg-cynog-IP2303-Ab-1/ GM-Tg-cynog-IP2303-Ab-2Anti-Cynomolgus/ Rhesus macaque ZDHHC16 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2303-Ab-1/ GM-Tg-felg-IP2303-Ab-2Anti-Feline ZDHHC16 monoclonal antibodyFeline
GM-Tg-cang-IP2303-Ab-1/ GM-Tg-cang-IP2303-Ab-2Anti-Canine ZDHHC16 monoclonal antibodyCanine
GM-Tg-bovg-IP2303-Ab-1/ GM-Tg-bovg-IP2303-Ab-2Anti-Bovine ZDHHC16 monoclonal antibodyBovine
GM-Tg-equg-IP2303-Ab-1/ GM-Tg-equg-IP2303-Ab-2Anti-Equine ZDHHC16 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2303-Ab-1/ GM-Tg-hg-IP2303-Ab-2; GM-Tg-rg-IP2303-Ab-1/ GM-Tg-rg-IP2303-Ab-2;
GM-Tg-mg-IP2303-Ab-1/ GM-Tg-mg-IP2303-Ab-2; GM-Tg-cynog-IP2303-Ab-1/ GM-Tg-cynog-IP2303-Ab-2;
GM-Tg-felg-IP2303-Ab-1/ GM-Tg-felg-IP2303-Ab-2; GM-Tg-cang-IP2303-Ab-1/ GM-Tg-cang-IP2303-Ab-2;
GM-Tg-bovg-IP2303-Ab-1/ GM-Tg-bovg-IP2303-Ab-2; GM-Tg-equg-IP2303-Ab-1/ GM-Tg-equg-IP2303-Ab-2
Products NameAnti-ZDHHC16 monoclonal antibody
Formatmab
Target NameZDHHC16
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-ZDHHC16 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2303-Ag-1Recombinant multi-species ZDH16/ ZDHHC16/ APH2 protein
    ORF Viral VectorvGMLP000096human ZDHHC16 Lentivirus particle
    ORF Viral VectorpGMLP000096human ZDHHC16 Lentivirus plasmid


    Target information

    Target IDGM-IP2303
    Target NameZDHHC16
    Gene ID84287,74168,654495,705982,486820,101099590,506085,100061023
    Gene Symbol and Synonyms1500015N03Rik,APH2,DHHC-16,ZDHHC16
    Uniprot AccessionQ969W1,Q58CU4
    Uniprot Entry NameZDH16_HUMAN,ZDH16_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000171307
    Target ClassificationN/A

    The target: ZDHHC16, gene name: ZDHHC16, also named as APH2, DHHC-16. Enables palmitoyltransferase activity. Involved in protein palmitoylation. Predicted to be located in endoplasmic reticulum membrane. Predicted to be integral component of membrane. Predicted to be active in Golgi apparatus. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.